news

Benenden Health has appointed Andy McClure as its chief commercial officer, responsible for commercial strategy.  McClure (pictured) previously held positions as marketing and propositions director for Axa Health, managing director for Marsh UK...

Diagnosing prostate cancer at a later stage can bring a treatment bill more than treble that for early diagnosis, along with the likelihood of worse health outcomes. Data from Healix Health found...

Bupa has launched a clinical training facility for healthcare professionals. While the facility has initially launched for just Bupa's employees, the provider told Health & Protection its plan is to also support...

Five years on from a global pandemic, employers appear to be continuing to carry the can when it comes to improving the health and productivity of UK plc's workforce. But this has...

The Exeter has seen a 10% increase in successful life claims, according to its 2024 claims statistics for health insurance, income protection, and life insurance products. The data reveals the UK protection...

Group income protection could become "much more mainstream" following the Mayfield review. This is according to Christian van Stolk, vice president of Rand Europe, (pictured), who was speaking at Western Provident Association's...

Isio has appointed Steve Thomson in a role covering client experience - wellbeing, risk and healthcare. Thomson joins the employee benefits consultancy after six months with Lockton where he was vice president,...

Employee assistance programmes (EAPs) on their own cannot fix UK plc's growing mental health crisis among younger workers. This is according to Dr Julie Denning, CEO of Working to Wellbeing (pictured), who...

Perci Health has closed a new £3m round, doubling its original £1.5m target. This brings the total the virtual cancer clinic has raised to £7.7m funding. This includes a £295,000 investment from...

Chris Lay, CEO of Marsh McLennan UK, has been appointed as campaign chairman for Insurance United Against Dementia (IUAD).  His appointment comes at an important time for dementia research, following the approval...